Healthtech Solutions Inc. (HLTT) Announces Appointment of Edward Swanson, MD as Company CEO
Dr. Swanson most recently co-founder of publicly listed PolarityTE, a biotech company focused around developing regenerative tissue products, biomaterials Prior to PolarityTE, Dr. Swanson served as resident in plastic and reconstructive surgery at John Hopkins University School of Medicine Healthtech Solutions has adopted a unique portfolio business model, recently announcing acquisition of precision oncology company Varian Biopharmaceuticals Healthtech Solutions (OTC: HLTT), the parent company of Varian Biopharmaceuticals Inc., Medi-Scan Inc. and RevHeart Inc., have recently announced the appointment of Edward Swanson, MD as the company’s new Chief Executive Officer (https://ibn.fm/444X7). The appointment, which is effective as of May 14, 2021,…